This product is for research use only, not for human use. We do not sell to patients.
Size | Price |
---|---|
250mg | Get quote |
500mg | Get quote |
1g | Get quote |
Cat #: V5277 CAS #: 1421502-62-6 Purity ≥ 98%
Description: PF-06263276 (PF6263276) is a novel, indazole-based, potent and selective pan-JAK inhibitor with anti- inflammatory and immunomodulatory effects. It inhibits JAK1/2/3 and TYK2 with IC50s of 2.2 nM, 23.1 nM, 59.9 nM and 29.7 nM, respectively. It is suitable for inhaled and topical delivery for the treatment of inflammatory diseases of the lungs and skin and was advanced into clinical studies. Janus kinases (JAKs) are a family of tyrosine kinases comprising four members (JAK1, -2, -3, and Tyk2). They play a critical role in both innate and adaptive immunity, since they function as key transducers in the signaling processes of many cytokine receptors.
Publications Citing InvivoChem Products
Product Promise
- Physicochemical and Storage Information
- Protocol
- Related Biological Data
- Stock Solution Preparation
- Quality Control Documentation
CAS No. | 1421502-62-6 |
---|---|
Storage | -20℃ for 3 years in powder form |
-80℃ for 2 years in solvent |
This equation is commonly abbreviated as: C1 V1 = C2 V2
- (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
- (2) Be sure to add the solvent(s) in order.